FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

31147511000001109: Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 03-Feb 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
96061501000001110 Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
96061601000001114 Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Topical route false Inferred relationship Existential restriction modifier
Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route cream.cutaneous ontology form and route true Inferred relationship Existential restriction modifier
Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream Has NHS dm+d (dictionary of medicines and devices) dose form indicator Continuous dose form indicator true Inferred relationship Existential restriction modifier
Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Cutaneous true Inferred relationship Existential restriction modifier
Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream Is a Salicylic acid + Propylene glycol + Clobetasol true Inferred relationship Existential restriction modifier
Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream Has dispensed dose form Cream true Inferred relationship Existential restriction modifier
Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream Has specific active ingredient Clobetasol propionate true Inferred relationship Existential restriction modifier
Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream Has specific active ingredient Propylene glycol true Inferred relationship Existential restriction modifier
Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream Has specific active ingredient Salicylic acid true Inferred relationship Existential restriction modifier
Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream Has active ingredient Propylene glycol true Inferred relationship Existential restriction modifier
Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream Has active ingredient Salicylic acid true Inferred relationship Existential restriction modifier
Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream Has active ingredient Clobetasol true Inferred relationship Existential restriction modifier
Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream Has manufactured dose form Cream false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream (Special Order) Is a True Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream Inferred relationship Existential restriction modifier
Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream 1 gram Has VMP True Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream Inferred relationship Existential restriction modifier
Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream 100 gram Has VMP True Salicylic acid 5% / Propylene glycol 47.5% in Clobetasol 0.05% cream Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start